Biolinq raked in $58 million in capital this week. The company is developing a wearable patch that uses electrochemical sensors to measure a person’s glucose levels from the intradermal space just beneath the surface of their skin.
Dexcom launched its first venture fund. The company, which makes continuous glucose monitors, plans to invest in glucose sensing technologies and metabolic monitoring.
Greenway Health blends smart technology with human expertise to elevate revenue cycle.
After going public last year, digital health startup Livongo saw its membership nearly double in 2019. The company saw significant uptake for its diabetes solution, a trend it expects to continue after striking several key partnerships.